NYSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis $5.42 -0.06 (-1.09%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$5.42 +0.00 (+0.09%) As of 04/25/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Bausch Health Companies Stock (NYSE:BHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BHC alerts:Sign Up Key Stats Today's Range$5.32▼$5.4850-Day Range$4.33▼$7.7152-Week Range$3.96▼$9.85Volume1.35 million shsAverage Volume2.71 million shsMarket Capitalization$1.99 billionP/E RatioN/ADividend YieldN/APrice Target$7.17Consensus RatingReduce Company OverviewBausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More… Bausch Health Companies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreBHC MarketRank™: Bausch Health Companies scored higher than 81% of companies evaluated by MarketBeat, and ranked 184th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingReduce Consensus RatingBausch Health Companies has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageBausch Health Companies has only been the subject of 2 research reports in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth5.67% Earnings GrowthEarnings for Bausch Health Companies are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -45.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -45.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.37. PEG Ratios below 1 indicate that a company could be undervalued.Read more about Bausch Health Companies' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.09% of the float of Bausch Health Companies has been sold short.Short Interest Ratio / Days to CoverBausch Health Companies has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bausch Health Companies has recently increased by 14.90%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBausch Health Companies does not currently pay a dividend.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth. Sustainability and ESG4.0 / 5Environmental Score-1.42 Percentage of Shares Shorted3.09% of the float of Bausch Health Companies has been sold short.Short Interest Ratio / Days to CoverBausch Health Companies has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bausch Health Companies has recently increased by 14.90%, indicating that investor sentiment is decreasing significantly. News and Social Media2.0 / 5News Sentiment0.67 News SentimentBausch Health Companies has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Bausch Health Companies this week, compared to 4 articles on an average week.Search InterestOnly 6 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.12% of the stock of Bausch Health Companies is held by insiders.Percentage Held by Institutions78.65% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Companies' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Stock News HeadlinesBausch Health announces launch of Solta Medical’s Fraxel FTXApril 26 at 7:52 AM | markets.businessinsider.comBausch Health Companies Inc.: Bausch Health Announces Launch of Solta Medical's Fraxel FTXApril 25 at 11:11 AM | finanznachrichten.deClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...April 26, 2025 | American Alternative (Ad)Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)April 25 at 11:11 AM | finance.yahoo.comBausch Health Companies (NYSE:BHC) Lowered to "Hold" Rating by StockNews.comApril 25 at 2:39 AM | americanbankingnews.comBillionaire Carl Icahn builds 34% economic interest in Bausch HealthApril 23 at 12:56 PM | msn.comIs Bausch Health Companies Inc. (BHC) the Best Canadian Penny Stock to Invest in Now?April 23 at 12:56 PM | msn.comBausch Health shares surge on Icahn’s significant economic interestApril 22, 2025 | in.investing.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at $8.06 on January 1st, 2025. Since then, BHC shares have decreased by 32.8% and is now trading at $5.42. View the best growth stocks for 2025 here. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (NYSE:BHC) announced its quarterly earnings results on Wednesday, February, 19th. The company reported $1.21 earnings per share for the quarter, missing the consensus estimate of $1.65 by $0.44. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative trailing twelve-month return on equity of 577.82% and a negative net margin of 0.48%. Read the conference call transcript. Who are Bausch Health Companies' major shareholders? Top institutional shareholders of Bausch Health Companies include SG Americas Securities LLC (0.78%), Intact Investment Management Inc. (0.05%), Range Financial Group LLC (0.04%) and Kendall Capital Management. View institutional ownership trends. How do I buy shares of Bausch Health Companies? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol-Myers Squibb (BMY) and Gilead Sciences (GILD). Company Calendar Last Earnings2/19/2025Today4/26/2025Next Earnings (Estimated)4/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSE:BHC CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees19,900Year FoundedN/APrice Target and Rating Average Stock Price Target$7.17 High Stock Price Target$8.50 Low Stock Price Target$3.00 Potential Upside/Downside+32.2%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E Ratio1.23 P/E Growth0.37Net Income$-46,000,000.00 Net Margins-0.48% Pretax Margin1.74% Return on Equity-577.82% Return on Assets5.24% Debt Debt-to-Equity RatioN/A Current Ratio0.86 Quick Ratio0.62 Sales & Book Value Annual Sales$9.63 billion Price / Sales0.21 Cash Flow$5.77 per share Price / Cash Flow0.94 Book Value($0.89) per share Price / Book-6.09Miscellaneous Outstanding Shares367,934,000Free Float338,058,000Market Cap$1.99 billion OptionableOptionable Beta0.43 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NYSE:BHC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.